Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compass: Urofollitropin vs r-hFSH for Ovulation Induction in Chinese Women
NCT01923194Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of urofollitropin in anovulatory infertility, sponsored by Ferring Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
urofollitropin
03
Conditions
anovulatory infertility
Beyond the preview
Go deeper on NCT01923194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01923194.